A family member is about to start chemotherapy, and you have heard the stories. The unpredictable, crushing side effects.

Relapsed blood cancer occurs when leukemia, lymphoma, or myeloma returns after initial remission, requiring specialized treatment pathways that differ fundamentally from first-line therapy based on disease biology, prior treatment response, transplant eligibility, and overall fitness. TL;DR Treatment resistance affects 30-40% of blood cancer patients, but salvage chemotherapy, targeted therapy, immunotherapy, stem cell transplant, and CAR-T therapy provide established pathway